The event will bring together over 2,000 exhibitors and 35,000+ industry professionals, buyers, and investors from India, Southeast Asia, and across the globe.

As India’s pharmaceutical industry gears up for robust expansion, the sector’s total market size is projected to reach USD 130 billion by 2030 and an impressive USD 450 billion by 2047, highlighting the country’s growing role as a global pharmaceutical powerhouse.

CPHI & PMEC India continues to serve as a premier global platform for pharmaceutical sourcing and innovation, connecting over 50,000 professionals from 120+ countries. The 2025 edition will feature the complete pharmaceutical value chain under one roof, encompassing formulations, APIs, excipients, packaging, machinery, and contract services, offering unparalleled opportunities for business networking, B2B matchmaking, and market insights.

Mr. Yogesh Mudras, Managing Director, Informa Markets in India, said: “The Indian pharmaceutical industry has evolved into one of the most dynamic and innovation-driven sectors globally, recognized for its world-class capability in producing affordable generics and life-saving vaccines. Ranking 3rd in pharmaceutical production by volume and contributing around 1.72% to the national GDP, the sector continues to play a pivotal role in driving economic growth and global healthcare accessibility. With the Union Budget 2025-26 proposing an allocation of over Rs. 5,268 crore to the Department of Pharmaceuticals, marking a nearly 29% increase from the previous year, the government’s continued focus on strengthening R&D, infrastructure, and capacity building further reinforces India’s vision of becoming a global hub for pharmaceutical innovation. Against this backdrop, CPHI & PMEC India 2025 serves as an ideal platform for strengthening collaboration, knowledge exchange, and strategic partnerships that will shape the future of India’s pharmaceutical landscape.”

CPHI & PMEC India will focus on key industry themes such as API self-reliance, sustainability, digitalization, and exports, highlighting India’s transition toward innovation-driven growth.

The event will showcase cutting-edge solutions in clean manufacturing, ESG compliance, and Pharma 4.0 technologies, aligning with the evolving needs of a future-ready pharma ecosystem.

Visitors can expect exciting product launches and breakthrough technology innovations, highlighting India’s growing capability in sustainable and high-value pharma manufacturing.

CPHI & PMEC India 2025 will welcome international exhibitors from China, Italy, Germany, Switzerland, and South Korea, among others, strengthening cross-border collaborations and export opportunities.

This year’s edition will also host the Pharma Leaders Roundtable, Women in Pharma Roundtable, the CPHI Pharma Awards, and the Pharma Connect Congress, offering a platform for policy dialogues, leadership exchange, and innovation-driven discussions.

The three-day event will also feature a comprehensive line-up of knowledge-led conferences and leadership dialogues, designed to drive strategic discussions and actionable insights for the pharmaceutical community. Key sessions will explore themes such as business sustainability in a shifting geopolitical landscape, reimagining innovation and manufacturing to enable transformative and affordable medicines, and enhancing patient centricity beyond GMP compliance.

Further, high-level panels will delve into charting the roadmap to meet sustainability goals and incorporating green design principles in pharma packaging and logistics to reduce carbon footprint, reflecting the industry’s collective vision towards responsible growth, innovation, and global competitiveness.

The event will see participation from leading exhibitors such as Dr. Reddy’s Laboratories Ltd., Hetero Labs Limited, Oceanic Pharmachem Pvt. Ltd., Akums Drugs & Pharmaceuticals Ltd., Morepen Laboratories Limited, MSN Laboratories Pvt. Ltd., Capsugel Healthcare Pvt. Ltd., Biocon Ltd., and Jubilant Ingrevia Ltd.

On the machinery side, PMEC India will feature top players including ACG Pam Pharma Technologies Pvt. Ltd., Cadmach Machinery Co. Pvt. Ltd., Ace Technologies & Packaging Systems Pvt. Ltd., Parle Global Technologies Pvt. Ltd., Klenzaids Contamination Controls Pvt. Ltd., Gansons Pvt. Ltd., Elmach Packages (India) Pvt. Ltd., NPM Machinery Pvt. Ltd., and Snowbell Machines Pvt. Ltd.

Supported by key industry associations such as Pharmexcil, International Pharmaceutical Excipients Council (IPEC) India, Bulk Drug Manufacturers Association of India (BDMAI), and Organisation of Pharmaceutical Producers of India (OPPI), along with participation from regulatory authorities and policymakers, the 2025 edition reinforces its position as a credible platform for policy advocacy, industry collaboration, and sustainable business growth.

With its global reach, comprehensive exhibit profile, and strong focus on innovation, CPHI & PMEC India 2025 continues to strengthen India’s role as the pharmacy of the world, fostering meaningful partnerships and charting the next phase of growth for the pharmaceutical industry.